Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
3387 | 1644 | 24.5 | 41% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
1 | 4 | ECONOMICS//EDUCATION & EDUCATIONAL RESEARCH//PSYCHOL | 3876184 |
110 | 3 | PSYCHIATRY//SCHIZOPHRENIA//BIPOLAR DISORDER | 71389 |
3387 | 2 | DIMEBON//REMOXIPRIDE//LATREPIRDINE | 1644 |
22258 | 1 | REMOXIPRIDE//AGONIST ANTAGONIST INTERACTION MODEL//1 2 DIAMINOCYCLOPROPANE | 388 |
22710 | 1 | ACTIVITAS NERVOSA SUPERIOR//COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS//11 4 CINNAMYL 1 PIPERAZINYL 6 11 DIHYDRODIBENZB EOXEPIN | 371 |
24718 | 1 | MEBEVERINE//LEVOSULPIRIDE//MEBEVERINE HYDROCHLORIDE | 303 |
28623 | 1 | DIMEBON//LATREPIRDINE//DIMEBOLIN | 203 |
28884 | 1 | METOCLOPRAMIDE//BROMOPRIDE//METOCLOPRAMIDE HYDROCHLORIDE | 197 |
29689 | 1 | 6 11 DIHYDRODIBENZB EOXEPIN//DIBENZOSUBERONE//ANTI PASSIVE CUTANEOUS ANAPHYLAXIS ACTIVITY | 182 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | DIMEBON | authKW | 405613 | 2% | 70% | 31 |
2 | REMOXIPRIDE | authKW | 235884 | 2% | 37% | 34 |
3 | LATREPIRDINE | authKW | 168835 | 1% | 91% | 10 |
4 | ACTIVITAS NERVOSA SUPERIOR | journal | 157030 | 5% | 9% | 90 |
5 | DIMEBOLIN | authKW | 118858 | 0% | 80% | 8 |
6 | MEBEVERINE | authKW | 116266 | 1% | 52% | 12 |
7 | LEVOSULPIRIDE | authKW | 116234 | 1% | 48% | 13 |
8 | NEURONAL NMDA RECEPTORS | authKW | 92861 | 0% | 100% | 5 |
9 | METOCLOPRAMIDE | authKW | 87001 | 3% | 9% | 55 |
10 | MEBEVERINE HYDROCHLORIDE | authKW | 84408 | 1% | 45% | 10 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Pharmacology & Pharmacy | 4600 | 32% | 0% | 526 |
2 | Chemistry, Medicinal | 2654 | 12% | 0% | 205 |
3 | Chemistry, Multidisciplinary | 1729 | 23% | 0% | 377 |
4 | Psychiatry | 945 | 10% | 0% | 158 |
5 | Chemistry, Analytical | 725 | 10% | 0% | 170 |
6 | Crystallography | 679 | 6% | 0% | 100 |
7 | Neurosciences | 562 | 13% | 0% | 215 |
8 | Clinical Neurology | 407 | 8% | 0% | 137 |
9 | Chemistry, Organic | 289 | 8% | 0% | 125 |
10 | Biochemical Research Methods | 137 | 4% | 0% | 66 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SECT MOL ECOGENET | 37140 | 0% | 50% | 4 |
2 | PHARMACEUT S 1188 SHIMOTOGARI | 33427 | 0% | 60% | 3 |
3 | PHYS CHEM IND CATALYSIS | 31829 | 0% | 29% | 6 |
4 | MOL BIOL HIGH THROUGHPUT SCREENING | 24761 | 0% | 67% | 2 |
5 | MOL ECOGENET GRP | 24761 | 0% | 67% | 2 |
6 | MOL STEM CELL PHARMACOL | 23875 | 0% | 43% | 3 |
7 | ABT GALEN | 18572 | 0% | 100% | 1 |
8 | ANORGAN DIDAKT CHEM | 18572 | 0% | 100% | 1 |
9 | BERLIN CLIN TERATOL | 18572 | 0% | 100% | 1 |
10 | BIOANAL ANALYT PHARMACEUT RD | 18572 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ACTIVITAS NERVOSA SUPERIOR | 157030 | 5% | 9% | 90 |
2 | COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS | 61233 | 9% | 2% | 155 |
3 | ACTA PSYCHIATRICA SCANDINAVICA | 4617 | 2% | 1% | 39 |
4 | SEMAINE DES HOPITAUX | 2859 | 1% | 1% | 23 |
5 | JOURNAL OF MEDICINAL CHEMISTRY | 2633 | 3% | 0% | 56 |
6 | ACTA PHARMACEUTICA NORDICA | 2460 | 0% | 3% | 5 |
7 | JOURNAL OF CRYSTALLOGRAPHIC AND SPECTROSCOPIC RESEARCH | 2230 | 1% | 1% | 11 |
8 | ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH | 1493 | 1% | 0% | 19 |
9 | ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS | 1370 | 2% | 0% | 28 |
10 | PSYCHOPHARMACOLOGY | 1335 | 2% | 0% | 30 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | DIMEBON | 405613 | 2% | 70% | 31 | Search DIMEBON | Search DIMEBON |
2 | REMOXIPRIDE | 235884 | 2% | 37% | 34 | Search REMOXIPRIDE | Search REMOXIPRIDE |
3 | LATREPIRDINE | 168835 | 1% | 91% | 10 | Search LATREPIRDINE | Search LATREPIRDINE |
4 | DIMEBOLIN | 118858 | 0% | 80% | 8 | Search DIMEBOLIN | Search DIMEBOLIN |
5 | MEBEVERINE | 116266 | 1% | 52% | 12 | Search MEBEVERINE | Search MEBEVERINE |
6 | LEVOSULPIRIDE | 116234 | 1% | 48% | 13 | Search LEVOSULPIRIDE | Search LEVOSULPIRIDE |
7 | NEURONAL NMDA RECEPTORS | 92861 | 0% | 100% | 5 | Search NEURONAL+NMDA+RECEPTORS | Search NEURONAL+NMDA+RECEPTORS |
8 | METOCLOPRAMIDE | 87001 | 3% | 9% | 55 | Search METOCLOPRAMIDE | Search METOCLOPRAMIDE |
9 | MEBEVERINE HYDROCHLORIDE | 84408 | 1% | 45% | 10 | Search MEBEVERINE+HYDROCHLORIDE | Search MEBEVERINE+HYDROCHLORIDE |
10 | GAMMA CARBOLINES | 83565 | 1% | 50% | 9 | Search GAMMA+CARBOLINES | Search GAMMA+CARBOLINES |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | PROTIVA, M , (1991) 50 YEARS IN CHEMICAL DRUG RESEARCH.COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS. VOL. 56. ISSUE 11B. P. 2501-2771 | 232 | 77% | 3 |
2 | PROTIVA, M , (1996) THE PLACE OF DIBENZO[B,F]THIEPIN DERIVATIVES IN MEDICINAL CHEMISTRY: STRUCTURES AND ACTIVITIES.JOURNAL OF HETEROCYCLIC CHEMISTRY. VOL. 33. ISSUE 3. P. 497-521 | 110 | 73% | 9 |
3 | CANO-CUENCA, N , DEL POZO, JSG , JORDAN, J , (2015) LATREPIRDINE: A SYSTEMATIC REVIEW OF THE PRECLINICAL STUDIES.REVISTA DE NEUROLOGIA. VOL. 60. ISSUE 1. P. 35 -42 | 31 | 67% | 0 |
4 | NAGUIB, IA , ABDELKAWY, M , (2010) DEVELOPMENT AND VALIDATION OF STABILITY INDICATING HPLC AND HPTLC METHODS FOR DETERMINATION OF SULPIRIDE AND MEBEVERINE HYDROCHLORIDE IN COMBINATION.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. VOL. 45. ISSUE 9. P. 3719-3725 | 34 | 62% | 17 |
5 | WADWORTH, AN , HEEL, RC , (1990) REMOXIPRIDE - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC POTENTIAL IN SCHIZOPHRENIA.DRUGS. VOL. 40. ISSUE 6. P. 863-879 | 43 | 86% | 48 |
6 | DEVI, OZ , BASAVAIAH, K , VINAY, KB , REVANASIDDAPPA, HD , (2012) DETERMINATION OF METOCLOPRAMIDE HYDROCHLORIDE IN PHARMACEUTICALS AND SPIKED HUMAN URINE THROUGH DIAZOTIZATION REACTION.JOURNAL OF FOOD AND DRUG ANALYSIS. VOL. 20. ISSUE 2. P. 454-463 | 23 | 82% | 2 |
7 | PETERS, OM , SHELKOVNIKOVA, T , TARASOVA, T , SPRINGE, S , KUKHARSKY, MS , SMITH, GA , BROOKS, S , KOZIN, SA , KOTELEVTSEVE, Y , BACHURIN, SO , ET AL (2013) CHRONIC ADMINISTRATION OF DIMEBON DOES NOT AMELIORATE AMYLOID-BETA PATHOLOGY IN 5XFAD TRANSGENIC MICE.JOURNAL OF ALZHEIMERS DISEASE. VOL. 36. ISSUE 3. P. 589-596 | 20 | 87% | 8 |
8 | USTYUGOV, A , SHEVTSOVA, E , BACHURIN, S , (2015) NOVEL SITES OF NEUROPROTECTIVE ACTION OF DIMEBON (LATREPIRDINE).MOLECULAR NEUROBIOLOGY. VOL. 52. ISSUE 2. P. 970 -978 | 28 | 56% | 1 |
9 | WALASH, M , EL-DIN, MS , EL-ENANY, N , EID, M , SHALAN, S , (2010) FIRST DERIVATIVE SYNCHRONOUS FLUORESCENCE SPECTROSCOPY FOR THE SIMULTANEOUS DETERMINATION OF SULPIRIDE AND MEBEVERINE HYDROCHLORIDE IN THEIR COMBINED TABLETS AND APPLICATION TO REAL HUMAN PLASMA.JOURNAL OF FLUORESCENCE. VOL. 20. ISSUE 6. P. 1275-1285 | 25 | 68% | 15 |
10 | LOUDERBACK, KM , WILLS, TA , MUGLIA, LJ , WINDER, DG , (2013) KNOCKDOWN OF BNST GLUN2B-CONTAINING NMDA RECEPTORS MIMICS THE ACTIONS OF KETAMINE ON NOVELTY-INDUCED HYPOPHAGIA.TRANSLATIONAL PSYCHIATRY. VOL. 3. ISSUE . P. - | 33 | 49% | 4 |
Classes with closest relation at Level 2 |